The objective of the study was to evaluate short-and long-term eVects of radiofrequency treatment of the soft palate on snoring. Twenty-nine patients with habitual snoring were studied prospectively and treated up to four times at 4-6 week intervals with an Ellman Surgitrone ® . Electromyography (EMG) of m. palatoglossus was performed in ten patients. Patients and partners evaluated snoring, sleep quality and daytime sleepiness 1 week preoperatively, 6 months and 3-4 years postoperatively. Snoring was reduced postoperatively (P < 0.0001). Sleep time increased, daytime sleepiness was reduced, and the partners slept better after 6 months. However, 3-4 years postoperatively only 25% of patients were satisWed. Another 25% had received additional treatment. EMG was normal in 6/10 patients preoperatively. They all continued to snore postoperatively. Four patients had pathological EMGs; three were responders. In conclusion, radiofrequency treatment for snoring may lead to long-term improvement in one out of four cases. Pre-evaluation with EMG may predict the outcome.
Introduction
Snoring is a very common and increasing problem in most societies. In telephone interviews of the general population, it was reported in 40% of UK subjects, 37% of German subjects and 20% of Italians [1] . In Sweden, 25% of females report snoring [2] as does 20% of the male population [3] . A treatment that reduces snoring, causes little discomfort, presents a low risk to the patient and is costeVective for society and therefore, is in great demand.
The majority of patients with obstructive sleep apnea syndrome (OSAS) reports being habitual snorers for years before the onset of daytime fatigue and witnessed apneas. The snoring sound is caused by the vibration of the soft tissue of the upper airway. The long-term use of hand-held vibrating tools may induce local peripheral nerve lesions of the hands [4] . In animal experiments, vibrating a limb will cause peripheral nerve lesions after a couple of weeks [5] . Therefore, it has been hypothesized that snoring-induced vibrations could cause obstructive sleep apnea (OSA) because of motor nerve lesions in the soft palate dilator muscles resulting in partial paresis [6] . This eVect on the palatal muscles has been studied in muscle biopsies from habitual snorers and OSAS patients [7] in which signs of peripheral nerve lesions were found in most OSAS cases and, to a lesser extent, in some snorers.
If snoring is an annoyance, is partly, depending on the sound pressure level per se but also on the sensitivity of the listeners [8] .The snoring sound is usually emitted by the uvula and soft palate irrespective of oral or nasal breathing. The tonsillar pillars and the walls of the pharynx and hypopharynx are exposed to the suction force (called the Bernoulli eVect), which may cause damage. The patient experiences a feeling of soreness in the throat and a lumpy sensation owing to a swollen uvula, especially in the morning. Some patients exhibit an acute edema of the uvula and may be suspected of having an infection, even though the likely cause is "a hard day's night" with excessive snoring vibrations.
Radiofrequency (RF) ablation of the soft palate heats the tissue around the electrode, disrupting the cells and inducing scariWcation/Wbrosis following the treatment. The amount of heat delivered is related to the content of Xuid in the tissue, the closeness to the antenna and the energy level used. A temperature level that does not cause nerve damage is preferable. An Ellman Surgitrone ® at 1.7 MHz will, if used according to the manual, heat the tissue to about 70°C, which will not burn the tissue, but will result in the preferred coagulation scariWcation.
The purpose of the present study was to investigate if treatment of the soft palate with RF waves can reduce snoring both on a short-and long-term basis, and whether or not this eVect is occurring in patients that already have signs of peripheral nerve lesions as recorded by electromyography (EMG).
Method
The study was approved by the regional ethics review committee of Linköping University. Inclusion criteria were habitual, socially disruptive snoring, an apnea-hypopnea index (AHI) <10 in a full night sleep respiratory recording, a body-mass index (BMI) <28 and no other known medical disease.
Twenty-six men and four women between 34 and 68 years of age (mean age 48 § 8.12 years) were included and gave an informed consent. Three ENT clinics participated (one university clinic and two clinics at county hospitals), each treating ten patients. The study started at diVerent times at the three participating clinics because the same RF equipment was used. Because of this, the longterm follow-up was about 4 years for the Wrst clinic and three for the last. The patients answered a questionnaire a week before the Wrst treatment, rating their own snoring habits, sleep quality and general health. This questionnaire (not validated) had been used for many years at the clinic, and data were available in the database for comparisons. They were also requested to keep a diary, made for the study, regarding their sleeping hours, disturbances of sleep, whether they felt refreshed in the mornings and if they had woken up with a sore throat or stuVy nose for a week before each RF treatment. Their partners also maintained their own diary describing their own sleep patterns and how often the patient's snoring each night woke them up. The same questionnaires were repeated 6 months after the last RF treatment. After 3-4 years of treatment, the patients were asked to do a new evaluation of their snoring on a visual analogue scale (VAS) at three diVerent time points: before the Wrst treatment, after the last treatment and at the present time. They were asked whether they were satisWed with their situation ("yes" or "no") with respect to current snoring or if they desired additional contact with a doctor. The patients were also asked if they had been or were presently exposed to other treatments for snoring since the last RF sessions.
EMG
The ten patients treated at the university clinic underwent an EMG examination of the soft palate immediately before the Wrst RF session. A disposable concentric bipolar EMG needle was used (Medtronic Inc., 75 cm length, recording tip 0.64 mm). Needle insertion was made at 2-4 points in the palatoglossal muscles: in the dimple and 1 cm to the left and right of the uvula. The signals were recorded on an EMG machine (Medelec Synergy, Oxford Instruments Inc.). This EMG technique has previously been described [6] . The following Wndings were regarded as pathological:
• Spontaneous activity (Wbrillation potentials, positive sharp waves) at rest, indicating an ongoing denervation.
• Polyphasic motor-unit potentials with increased amplitudes (>2 mV) and/or duration, indicating a reinnervation process (i.e., evidence of a previous denervation).
• A reduced interference pattern despite high Wring frequency at maximal voluntary contraction, indicating a loss of motor units typical of peripheral nerve lesions.
For the statistical analysis, the EMG Wndings were given numerical values. Normal Wndings were designated 0. The degree of pathology was scored as mild (level 1) if polyphasic or amplitude-increased motor-unit potentials were present. The degree of pathology was scored as moderate (level 2) if both changes in motor-unit potential conWguration and reduced amount of voluntary activity were recorded. The degree of pathology was scored as high (level 3) if spontaneous denervation activity was present together with reduced voluntary activity, or if the maximum voluntary activity was reduced to the point where only single potentials could be recorded.
RF treatment
The RF treatments were performed with Ellman Surgitrone at 1.7 MHz (Ellman International 3333 Royal Ave Oceanside, NY 11572 USA) as an oYce procedure under local anesthesia. The same study protocol was used for all patients. All participating otorhinolaryngologists were instructed to follow the protocol with respect to treatment points, duration and output level. The Wrst treatment session for each surgeon was performed together with the Wrst author (EH).
During the Wrst session, four locations of the soft palate were treated with two insertion points (Fig. 1) following injection of 1% Lidocain-adrenalin (1 cc) at each treatment point. During the second through fourth sessions, two spots were usually treated. The Surgitrone ® was activated after the instrument tip was placed into the palatal muscles. A neutral electrode placed on the patient's neck acted as an antenna. With 20% output (i.e., coagulation mode), the electrode was activated for up to 20 s. During the Wrst treatment session of the Wrst Wve patients, the rear side of the soft palate was simultaneously observed by Wberoptics to ensure that the electrode placement was not too deep. If the mucous membrane surface turned whitish, the electrode placement was determined to be too superWcial and the treatment was ended.
Following the procedure, paracetamol (1 g three times/ day) was prescribed to be taken as long as necessary. Patients were told each day to register the experienced maximal pain level on a three-grade scale (no pain, some pain and severe pain). The analgesics were taken until patients were free of pain.
After 2 weeks of treatment, patients were contacted via telephone to evaluate their situation. If no eVect on snoring was noticed, a new appointment for treatment was scheduled approximately 6 weeks after the Wrst. The patient was asked to keep a new diary the week before the next treatment. No more than four treatment sessions were planned for this study.
Statistics
Descriptive statistics were used and a Wilcoxon signed rank test was used for dependent variables and for nonparametric variables from the diaries (i.e., snoring and the Epworth sleepiness scale). A 2 test was used to compare hours of sleep.
Results
Twenty-nine patients were treated according to the protocol. One patient with type II diabetes got a purulent infection in the palate after the Wrst treatment and was, therefore, excluded. Most patients were treated four times (mean = 3.6).
All 29 patients were both seen at the 6-month follow-up and answered the mailed follow-up inquiry after a mean of 40.3 § 7.7 months (3-4 years).
The post-treatment pain had been almost negligible. Five patients got small ulcers at the insertion sites. These ulcers healed with very little pain within a couple of weeks. The patients followed the prescribed course of paracetamol for the Wrst 3 days and none reported more than a pain level of two on the three-graded scale.
The data for snoring at the three measuring points are shown in Fig. 2 . The median snoring VAS score before RF treatment was 8.6, diminishing to 3.6 after 6 months (P < 0.0001) and increasing to 5.0 after 3 years. Eleven patients reported a VAS score for snoring ·5 after 3-4 years. Eight of the 29 (28%) patients reported a decrease in snoring to half or less compared with their own baseline ("responders"). These eight responders experienced less daytime sleepiness at the follow-up than before treatment and were more satisWed. Those who were still snoring had a considerably higher score on ESS and were unsatisWed.
The ESS score at the long-term follow-up was 9.8 § 5.2. The results concerning snoring, ESS and "satisfaction with present situation regarding snoring" are shown in Table 1 . There was a signiWcant correlation between the degree of snoring as measured by a VAS (0-10), and daytime sleepiness as measured by the ESS scale (0-20; adjusted R 2 = 0.23, P = 0.005; Fig. 3 ). There was also an inverse relationship between patient "satisfaction" and "degree of snoring" (R 2 = 0.58384694, P = 0.000001, Fig. 4) . Pre-treatment EMG in 10 patients: 0 = no pathology, 1 = mild pathology, 2 = severe pathology. ESS after 4 years. Additional treatment after RF. "Responders" (<50% reduction) with respect to snoring after 4 years are marked a Evalution after "additional treatment" 
ESS 4 years
Few diaries were completed both by patients and partners for all requested times. Only 10 patients could be evaluated by the comparison of the answers before the Wrst and the fourth treatments and also after 6 months. The number of awakenings each night, as a sign of disturbed sleep for both the patient and the partner, was reduced during the treatment period. The patients and partners reported an increase in sleeping hours as a measure of quality of sleep during the treatment period. However, sleeping time, was back to baseline for the patients after 6 months post-surgery, but the partners were in many cases still sleeping longer (Fig. 5) .
After the end of the project, eight patients had received additional treatment for snoring such as mandibular advancement devices (n = 4), CPAP (n = 1) or RFUPP (n = 3). The reasons reported for additional treatment were that the patients had not experienced signiWcant improvements following the RF treatment. In two cases, an increased AHI was registered after treatment and resulted in further therapy.
EMG Wndings
The results for the 10 out of 29 patients who were examined with EMG before the Wrst RF treatment are presented in Table 1 . Denervation activity was never observed. Five patients had normal EMGs, and three had minor changes in the form of polyphasic and/or amplitude-increased motorunit potentials (indicating a long-standing process with some re-innervation). Two patients had more pronounced changes with decreased voluntary activity, indicating a loss of motor units. The Wve patients with normal preoperative EMGs all reported continued snoring after treatment, whereas four of the Wve patients with pathological EMG (two patients with grade 1 changes and two with grade 2 changes) had a signiWcant long-lasting improvement at the 4 years control.
Discussion
This study demonstrates a temporary eVect on snoring for most patients after volume reductive/stiVening RF treatment of the soft palate. This is in agreement with the earlier investigations [9] [10] [11] [12] . Those studies, however, did not have as long follow-up time as that of the present investigation. One out of four patients in the present study exhibited a more permanent "cure". An interesting question is, thus, whether a positive result could have been predicted before treatment. All Wve patients with normal EMGs and one with grade 1 (mild) pathology either received additional treatment or were not satisWed after 3-4 years because they snored as much as they did before the Wrst treatment. Of the four out of 10 patients who were regarded as responders after 3-4 years, two had pathological grade 2 EMGs and two had grade 1 EMGs before treatment. In another study where OSA patients, snorers and non-snoring persons were examined with EMG, a successive grading of nerve degeneration was observed with less damage in snorers and more in OSAS patients [13] . This may indicate that for a habitual snorer without neurological vibration damage, the small scar tissue centers created by the RF treatment were not large enough to stop the vibrations of the palate. If nerve damage was already present, however, the delivered stiVening of the scarring process seemed to be suYcient. It is possible that further treatment sessions or more treatment points during each session could have also improved the snoring for patients with normal EMGs.
The RF treatment was uncomplicated and almost painfree for all "otherwise healthy" patients. The risk for infec- 
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tion has always to be taken into consideration for people with compromised immune systems (e.g. diabetes). Such patients should probably not be recommended for this kind of treatment.
The RF treatment in the present form cannot be regarded as cost-eVective, especially with only 28% of the treated patients "cured" after 3-4 years. This has to be compared with other treatments for snoring, such as surgery or mandibular advancement devices (MAD). With respect to surgery, uvulopalatopharyngoplasty (UPP) has approximately 40-80% responders after the same time period [14] [15] [16] . With respect to MAD, the compliance after 4 years still is 62% [17] . On the other hand, the treatment with RF causes much less pain than all surgical modalities [18, 19] and does not require sick leave, which may, therefore, be more economical not only for some patients, but also for society.
A mode to predict positive outcome would be desirable for the RF method. Otherwise, four treatments of 30 patients (a total of 104 sessions) to get 4-5 responders after 3-4 years are considered unreasonable. An EMG examination before the treatment may be such a predictor. The small number of EMG-examined patients in the present study unfortunately makes it impossible to state the predictive value, but it may be an interesting point to evaluate in a future, more extended study.
Conclusion
Intrapalatal treatment with RF for snoring may in one case of four lead to long-term improvement (3-4 years). All cases with normal EMG before treatment were nonresponders.
